FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3091493102> ?p ?o ?g. }

• W3091493102 endingPage "104330" @default.
• W3091493102 startingPage "104330" @default.
• W3091493102 abstract "Targeting VEGFR-2 signaling pathway is well-established as an important approach for the treatment of solid tumors, particularly renal cancer. Herein, novel indolyl-1,2,4-triazole hybrids were designed and synthesized as VEGFR-2 kinase inhibitors with potential anti-renal cancer activity. The structures of the newly synthesized compounds were confirmed based on their spectral and elemental analyses. The results of in vitro kinase assay indicated that all target compounds revealed submicromolar inhibition of VEGFR-2 kinase enzyme. Analogs 5c, 5d and 9b emerged as the most active compounds (IC50 = 0.034–0.064 µM), showing VEGFR-2 inhibitory activity much superior to that of sunitinib reference drug (IC50 = 0.075 µM). Moreover, compounds 5a, 8c, 9d, 12c were equipotent to sunitinib against VEGFR-2 kinase. Additionally, the most potent compounds were further examined for their anticancer activity against two human renal cancer cell lines. All screened compounds effectively inhibited the growth of the two tested cell lines with IC50 values spanning from sub-micromolar to low micromolar levels. Compounds 5b, 5d, 11c and 12c were three to five-fold more potent than sunitinib against CAKI-1 cell line. Analogue 8c was superior/comparable to sunitinib against CAKI-1/A498 cell lines. Moreover, compound 9d showed double potency of sunitinib against A498 cell line. Besides, compounds 8c and 12c demonstrated a safety profile much better than that of sunitinib against non-cancer human renal cells. As well, the docked models of title compounds revealed strong interactions with key residues within the active site of VEGFR-2 kinase." @default.
• W3091493102 created "2020-10-08" @default.
• W3091493102 creator A5015817802 @default.
• W3091493102 creator A5030342815 @default.
• W3091493102 creator A5039363446 @default.
• W3091493102 creator A5041779333 @default.
• W3091493102 creator A5069401469 @default.
• W3091493102 creator A5087324539 @default.
• W3091493102 date "2020-12-01" @default.
• W3091493102 modified "2023-10-02" @default.
• W3091493102 title "Discovery of novel indolyl-1,2,4-triazole hybrids as potent vascular endothelial growth factor receptor-2 (VEGFR-2) inhibitors with potential anti-renal cancer activity" @default.
• W3091493102 cites W1122241379 @default.
• W3091493102 cites W1968930571 @default.
• W3091493102 cites W1972739162 @default.
• W3091493102 cites W1987977871 @default.
• W3091493102 cites W1989280181 @default.
• W3091493102 cites W1993205943 @default.
• W3091493102 cites W1998976814 @default.
• W3091493102 cites W2009880338 @default.
• W3091493102 cites W2009968499 @default.
• W3091493102 cites W2019174178 @default.
• W3091493102 cites W2059981607 @default.
• W3091493102 cites W2063544208 @default.
• W3091493102 cites W2064360454 @default.
• W3091493102 cites W2067216473 @default.
• W3091493102 cites W2082817448 @default.
• W3091493102 cites W2114918609 @default.
• W3091493102 cites W2144441413 @default.
• W3091493102 cites W2144707486 @default.
• W3091493102 cites W2153331460 @default.
• W3091493102 cites W2210616237 @default.
• W3091493102 cites W2304808344 @default.
• W3091493102 cites W2330896126 @default.
• W3091493102 cites W2395949948 @default.
• W3091493102 cites W2518977301 @default.
• W3091493102 cites W2530373047 @default.
• W3091493102 cites W2567761151 @default.
• W3091493102 cites W2574576254 @default.
• W3091493102 cites W2752094938 @default.
• W3091493102 cites W2767678868 @default.
• W3091493102 cites W2884186513 @default.
• W3091493102 cites W2885738414 @default.
• W3091493102 cites W2951185063 @default.
• W3091493102 cites W2969056237 @default.
• W3091493102 cites W2990686724 @default.
• W3091493102 cites W2995463243 @default.
• W3091493102 cites W2996429326 @default.
• W3091493102 cites W3000789918 @default.
• W3091493102 cites W3011543462 @default.
• W3091493102 cites W3014897952 @default.
• W3091493102 cites W3044294667 @default.
• W3091493102 cites W3080745443 @default.
• W3091493102 cites W2948843736 @default.
• W3091493102 doi "https://doi.org/10.1016/j.bioorg.2020.104330" @default.
• W3091493102 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33038552" @default.
• W3091493102 hasPublicationYear "2020" @default.
• W3091493102 type Work @default.
• W3091493102 sameAs 3091493102 @default.
• W3091493102 citedByCount "30" @default.
• W3091493102 countsByYear W30914931022020 @default.
• W3091493102 countsByYear W30914931022021 @default.
• W3091493102 countsByYear W30914931022022 @default.
• W3091493102 countsByYear W30914931022023 @default.
• W3091493102 crossrefType "journal-article" @default.
• W3091493102 hasAuthorship W3091493102A5015817802 @default.
• W3091493102 hasAuthorship W3091493102A5030342815 @default.
• W3091493102 hasAuthorship W3091493102A5039363446 @default.
• W3091493102 hasAuthorship W3091493102A5041779333 @default.
• W3091493102 hasAuthorship W3091493102A5069401469 @default.
• W3091493102 hasAuthorship W3091493102A5087324539 @default.
• W3091493102 hasConcept C121608353 @default.
• W3091493102 hasConcept C126322002 @default.
• W3091493102 hasConcept C184235292 @default.
• W3091493102 hasConcept C185592680 @default.
• W3091493102 hasConcept C202751555 @default.
• W3091493102 hasConcept C2777752497 @default.
• W3091493102 hasConcept C2779490328 @default.
• W3091493102 hasConcept C502942594 @default.
• W3091493102 hasConcept C54355233 @default.
• W3091493102 hasConcept C55493867 @default.
• W3091493102 hasConcept C71924100 @default.
• W3091493102 hasConcept C81885089 @default.
• W3091493102 hasConcept C86803240 @default.
• W3091493102 hasConcept C96232424 @default.
• W3091493102 hasConcept C98274493 @default.
• W3091493102 hasConceptScore W3091493102C121608353 @default.
• W3091493102 hasConceptScore W3091493102C126322002 @default.
• W3091493102 hasConceptScore W3091493102C184235292 @default.
• W3091493102 hasConceptScore W3091493102C185592680 @default.
• W3091493102 hasConceptScore W3091493102C202751555 @default.
• W3091493102 hasConceptScore W3091493102C2777752497 @default.
• W3091493102 hasConceptScore W3091493102C2779490328 @default.
• W3091493102 hasConceptScore W3091493102C502942594 @default.
• W3091493102 hasConceptScore W3091493102C54355233 @default.
• W3091493102 hasConceptScore W3091493102C55493867 @default.
• W3091493102 hasConceptScore W3091493102C71924100 @default.
• W3091493102 hasConceptScore W3091493102C81885089 @default.
• W3091493102 hasConceptScore W3091493102C86803240 @default.

• next